DaVita Corp (DVA) - Kewajiban jangka dawa marang modal

DaVita Corp - logo grafis emiten DVA

The price action of DaVita Inc. (DVA) reflects the performance of a company whose authority among physicians and patients is built on the impeccable quality of life-sustaining treatment. The business seeks dominance in the dialysis segment by implementing home-based therapies and reducing clinic network costs, while the metric stands at 0.00. Stable revenue is driven by high center occupancy and the continuous upgrading of medical equipment.

davita.com (DVA): Rasio utang jangka dawa marang ekuitas saka 04.07.2022 nganti 31.10.2026
Produk mawa merek DaVita Inc

For the largest dialysis center operator DaVita Inc. (DVA), whose operations depend critically on patient trust, maintaining financial stability is a priority. The current value of 0.00 reflects the long-term debt-to-equity ratio, making it possible to distinguish actual loan repayments from share dilution via secondary offerings. By analyzing the proportion of long-term loans to equity, an investor assesses bankruptcy risk and the effectiveness of the company's debt strategy.

Perusahaan pesaing

HCA: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal THC|FMS - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal SOLV (Solventum Corporation)|Utang jangka dawa marang modal encompasshealth.com EHC|UHS: Rasio utang jangka dawa marang ekuitas|RadNet Inc - Rasio silihan jangka dawa marang modal|Option Care Health Inc (OPCH) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Surgery Partners Group|PINC (Premier, Inc.) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal nationalvision.com EYE|Utang jangka dawa marang ekuitas Progyny (PGNY)|Ardent Health - Rasio utang jangka dawa marang modal|Select Medical Corp - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal ASTH (Astrana Corp)|Pediatrix - Utang jangka dawa marang modal|USPH (U.S. Physical Therapy) - Rasio utang jangka dawa marang modal|PNTG: Utang jangka dawa marang modal|Organogenesis Holdings Inc. (ORGO) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas NUTX|Utang jangka dawa marang ekuitas AUNA|Utang jangka dawa marang modal SBC|Rasio tanggungan utang jangka dawa marang modal evolus.com|Community Health Systems, Inc. - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal SKIN (The Beauty Health Company)|MediWound, Ltd. - Utang jangka dawa marang modal|BTMD - Utang jangka dawa marang modal|JYNT (The Joint Corp.) - Rasio utang jangka dawa marang ekuitas|docgo.com - Koefisien utang jangka dawa marang modal|PIII (P3 Health Partners, Inc.) - Utang jangka dawa marang modal|Gain Therapeutics Inc. (GANX) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas EUDA Health (EUDA)|baselmedical.com - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal CLGN (CollPlant Biotechnologies Ltd.)|CUPR - Rasio utang jangka dawa marang ekuitas|CCM: Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal American Shared Hospital Services Inc AMS|MRM: Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal ALBT|Rasio utang jangka dawa marang ekuitas DHAI|Utang jangka dawa marang ekuitas XAGE|Utang jangka dawa marang modal NIVF|Utang jangka dawa marang modal atipt.com (ATIP)|CareMax Medical Group - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal KDLY (Kindly Health)|MODV - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal NVOS (novointegrated.com)|SSY: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal IMAC Holdings Inc (BACK)